Similar articles

• Randomized controlled trial of pyrimethamine plus sulfadiazine versus trimethoprim plus sulfamethoxazole for treatment of toxoplasmic encephalitis in AIDS patients.

  Kongsaengdao S, Samintarapanya K, Oranratnachai K, Prapakarn W, Apichartpiyakul C. Kongsaengdao S, et al. J Int Assoc Physicians AIDS Care (Chic). 2008 Jan-Feb;7(1):11-6. doi: 10.1177/1545109707301244. Epub 2007 May 21. J Int Assoc Physicians AIDS Care (Chic). 2008. PMID: 17517949 Clinical Trial.
• Empiric treatment of acute Toxoplasma encephalitis in patients with acquired immunodeficiency syndrome.

  Iribarren JA, Arrizabalaga J, Garde C, Rodriguez-Arrondo F, Blanco A. Iribarren JA, et al. Arch Intern Med. 1992 Oct;152(10):2139-40. Arch Intern Med. 1992. PMID: 1417389 No abstract available.
• Thrice-weekly sulfadiazine-pyrimethamine for maintenance therapy of toxoplasmic encephalitis in HIV-infected patients. Spanish Toxoplasmosis Study Group.

  Podzamczer D, Miró JM, Ferrer E, Gatell JM, Ramón JM, Ribera E, Sirera G, Cruceta A, Knobel H, Domingo P, Polo R, Leyes M, Cosin J, Fariñas MC, Arrizabalaga J, Martínez-Lacasa J, Gudiol F. Podzamczer D, et al. Eur J Clin Microbiol Infect Dis. 2000 Feb;19(2):89-95. doi: 10.1007/s100960050436. Eur J Clin Microbiol Infect Dis. 2000. PMID: 10746493 Clinical Trial.
• Issues in toxoplasmosis.

  McCabe R, Chirurgi V. McCabe R, et al. Infect Dis Clin North Am. 1993 Sep;7(3):587-604. Infect Dis Clin North Am. 1993. PMID: 8254161 Review.
• Movement disorders with cerebral toxoplasmosis and AIDS.

  Nath A, Hobson DE, Russell A. Nath A, et al. Mov Disord. 1993;8(1):107-12. doi: 10.1002/mds.870080119. Mov Disord. 1993. PMID: 8419793 Review.